Newsroom

LONDON--(BUSINESS WIRE)--  Xtrackers (IE) plc Investment Company with Variable Capital Registered Office: 78 Sir John Rogerson's Quay, Dublin 2, Ireland Registration number: 393802 (“the Company”) Important Notice to Shareholders of: Xtrackers US Equity Enhanced Active UCITS ETF (ISIN: IE0002PGSLZ5) Xtrackers World Equity Enhanced Active UCITS ETF (ISIN: IE00094GSCQ4) (each a “Fund” and together the “Funds”) _________________________________________________________________________________ 16 De...

NEW YORK--(BUSINESS WIRE)--  16th December 2025 CRH plc Transaction in Own Shares CRH plc (“CRH”) announces that on 15th December 2025 it acquired the following number of its ordinary shares (the “ordinary shares”) in the United States through CRH’s broker Santander US Capital Markets LLC. The ordinary shares acquired (by way of redemption) will be cancelled. Aggregate number of ordinary shares acquired Daily volume weighted average price paid Daily highest price paid per share Daily lowest pri...

LONDRES--(BUSINESS WIRE)--ThetaRay, líder internacional en cumplimiento de la normativa contra delitos financieros con IA cognitiva, ha publicado hoy un estudio sin precedentes sobre el futuro de la lucha contra el blanqueo de capitales en Europa. El estudio advierte de que el sistema europeo contra el blanqueo de capitales (AML) se acerca a un colapso estructural y que las instituciones financieras no podrán cumplir las futuras expectativas de supervisión sin sistemas avanzados de supervisión...

LONDRES--(BUSINESS WIRE)--ThetaRay, chef de file mondial de la conformité en matière de criminalité financière alimentée par l'IA cognitive, a publié aujourd'hui une étude de référence sur l'avenir de la lutte contre le blanchiment d'argent en Europe. Cette étude met en garde contre le risque de défaillance structurelle du système européen de lutte contre le blanchiment d'argent (LCB-FT) et l'incapacité des institutions financières à répondre à l'avenir aux futures exigences des autorités de su...

LONDON--(BUSINESS WIRE)--Amazon and Apple accused of colluding to increase Apple product prices, causing millions of loyal UK customers to overpay...

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For...

新加坡--(BUSINESS WIRE)--(美國商業資訊)-- 位於新加坡JTC LaunchPad的垂直整合細胞及衍生物CRDMO公司Esco Aster宣布，Shine-On Biomedical靶向HLA-G的外泌體項目提供CMC生產支持。Shine-On Biomedical於2023年委託Esco Aster提供cGMP服務，從利用Esco Aster的細胞株平台進行高產量外泌體開發開始。製程、分析與配方開發、外泌體藥物裝載、GMP工程運行以及穩定性研究的技術報告，均支持了Shine-On的IND提交。該IND已於2025年第一季獲得美國FDA核准。 此外，Esco Aster正依據Shine-On的指示，為探索性外泌體裝載可行性研究提供技術服務。Shine-On Biomedical是一家基於外泌體藥物傳遞的新興創新者。 Shine-On的專有產品SOB100是一種靶向HLA-G的外泌體藥物傳遞載體，已通過美國FDA的IND審查並正在進行第一階段研究，使其成為一個首創、具有潛力的HLA-G靶向外泌體藥物開發平台。 Shine-On Biomedical總經理Hung-Ch...

新加坡--(BUSINESS WIRE)--(美国商业资讯)-- 立足于新加坡JTC LaunchPad的垂直整合细胞及衍生物CRDMO企业Esco Aster宣布，将为Shine-On Biomedical的HLA-G靶向外泌体项目提供CMC生产支持。Shine-On Biomedical于2023年委托Esco Aster开展cGMP服务，初期利用Esco Aster的细胞系平台进行高产外泌体开发。工艺开发、分析方法开发、配方开发、外泌体药物负载、GMP工程化运行及稳定性研究等技术报告，为Shine-On提交新药临床试验申请（IND）提供了支持。该IND申请已于2025年第一季度获得美国FDA批准。 此外，Esco Aster还根据Shine-On的指示，提供探索性外泌体载药可行性研究的技术服务。Shine-On Biomedical是一家新兴的基于外泌体的药物递送创新企业。 ShineOn的专有产品SOB100是一种HLA-G靶向外泌体药物递送载体，已通过美国FDA IND审查，并正在进行I期研究，使其成为同类首创的HLA-G靶向外泌体药物开发平台。 Shine-On Biome...

LONDON & SAN FRANCISCO--(BUSINESS WIRE)--Today, Latent Labs announces Latent-X2, a frontier AI model that can design drug-like biologics without iteration. Drug hunters can use Latent Lab's AI platform, built on Latent-X2, to access difficult targets and accelerate development timelines by reducing wet lab work. The generated designs display drug-like properties including low ex vivo immunogenicity, significantly shortening the path from hit to clinical candidate. Alongside the release, Latent...

LONDON--(BUSINESS WIRE)--Volante Technologies, the global leader in Payments as a Service (PaaS), today announced it has successfully upgraded its clients to meet the latest SEPA Instant Payments Regulation (IPR) and SWIFT SRG 2025 mandate, which came into effect October 9th and November 22nd, 2025, respectively. This announcement follows the major FedISO upgrade in July, which shifted trillions of dollars in payments to the new ISO 20022 messaging format. SEPA IPR is a significant European mil...